These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 11214247)

  • 1. Use and validation of an NMR test for the identity and O-acetyl content of the Salmonella typhi Vi capsular polysaccharide vaccine.
    Lemercinier X; Martinez-Cabrera I; Jones C
    Biologicals; 2000 Mar; 28(1):17-24. PubMed ID: 10799051
    [No Abstract]   [Full Text] [Related]  

  • 2. Physical, chemical, antigenic, and immunologic characterization of polygalacturonan, its derivatives, and Vi antigen from Salmonella typhi.
    Szu SC; Bystricky S
    Methods Enzymol; 2003; 363():552-67. PubMed ID: 14579603
    [No Abstract]   [Full Text] [Related]  

  • 3. Physical and chemical parameters for the characterisation of the group C polysaccharide of the Cuban meningococcal BC vaccine.
    Martinez-Cabrera I; Muñoz Y; Fajardo EM; Jones C; Lemercinier X; Crane D; Cuevas M; Duarte M; Moreira T; Campa C; Abreu J
    Dev Biol (Basel); 2000; 103():267-8. PubMed ID: 11214248
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Vi polysaccharide vaccine against Salmonella typhi.
    Arya SC
    Vaccine; 1999 Mar; 17(9-10):1015-6. PubMed ID: 10195609
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary physical and chemical characterisation of Salmonella typhi VI polysaccharide.
    Martinez-Cabrera I; Muñoz Y; Riverón L; Jones C; Lemercinier X; Duarte M; Nápoles L; Muñoz X
    Dev Biol (Basel); 2000; 103():265-6. PubMed ID: 11214247
    [No Abstract]   [Full Text] [Related]  

  • 7. A new typhoid vaccine composed of the Vi capsular polysaccharide.
    Plotkin SA; Bouveret-Le Cam N
    Arch Intern Med; 1995 Nov; 155(21):2293-9. PubMed ID: 7487253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines against typhoid fever.
    Guzman CA; Borsutzky S; Griot-Wenk M; Metcalfe IC; Pearman J; Collioud A; Favre D; Dietrich G
    Vaccine; 2006 May; 24(18):3804-11. PubMed ID: 16278037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization against typhoid: a short review.
    Bhatia RS; Sibia SS
    J Assoc Physicians India; 1994 May; 42(5):424. PubMed ID: 7829448
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analysis of Vi antigen genes of Salmonella typhi and study of its regulation].
    Hashimoto Y
    Nihon Saikingaku Zasshi; 1997 Oct; 52(4):649-57. PubMed ID: 9391317
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica Serovar Typhi strains used as live oral vaccines in humans.
    Sztein MB
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S15-9. PubMed ID: 17582562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physico-chemical characterization of polysaccharide vaccines.
    Egan W
    Dev Biol (Basel); 2000; 103():3-9. PubMed ID: 11214251
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.